Cargando…
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
Background: Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) is a negative immune regulator on the surface of T cells. In humans, heterozygous germline mutations in CTLA4 can cause an immune dysregulation syndrome. The phenotype comprises a broad spectrum of autoinflammatory, autoimmune, and imm...
Autores principales: | Egg, David, Schwab, Charlotte, Gabrysch, Annemarie, Arkwright, Peter D., Cheesman, Edmund, Giulino-Roth, Lisa, Neth, Olaf, Snapper, Scott, Okada, Satoshi, Moutschen, Michel, Delvenne, Philippe, Pecher, Ann-Christin, Wolff, Daniel, Kim, Yae-Jean, Seneviratne, Suranjith, Kim, Kyoung-Mee, Kang, Ji-Man, Ojaimi, Samar, McLean, Catriona, Warnatz, Klaus, Seidl, Maximilian, Grimbacher, Bodo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140401/ https://www.ncbi.nlm.nih.gov/pubmed/30250467 http://dx.doi.org/10.3389/fimmu.2018.02012 |
Ejemplares similares
-
Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry
por: Rojas-Restrepo, Jessica, et al.
Publicado: (2023) -
Correction to: Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4‑Dependent Transendocytosis by Flow Cytometry
por: Rojas‑Restrepo, Jessica, et al.
Publicado: (2023) -
Autosomal-dominant immune dysregulation syndrome in humans with CTLA4 mutations
por: Schubert, Desirée, et al.
Publicado: (2014) -
14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency
por: Schepp, Johanna, et al.
Publicado: (2017) -
The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial
por: Krausz, Máté, et al.
Publicado: (2022)